Generics - GlaxoSmithKline


Current filters:


Popular Filters

1620 to 1643 of 1643 results

US FDA consults on user fee program for biosimilar and interchangeable biologicals


The US Food and Drug Administration is requesting input from stakeholders and the public relating to…

BiotechnologyGenericsNorth AmericaPharmaceuticalRegulation

India set to become global leader in APIs industry


Low-cost manufacturing facilities and abundant talent pool will drive the growth of India in the global…

Asia-PacificGenericsMarkets & Marketing

Growth in Canadian drug spending slows to lowest rate since 1996


Although drugs remain an important cost driver in Canada’s health system, growth in spending has…

GenericsHealthcareNorth AmericaPharmaceuticalPricing

Nigerian government plans local production of anti-malaria drugs


To further reduce the cost of anti-malaria drug and reduce malaria incidence to the barest minimum, the…

GenericsMarkets & MarketingPharmaceuticalPoliticsRest of the WorldTropical diseases

Australian generic drugmakers welcome IP law to encourage R&D investment


Members of Australia’s Generic Medicines Industry Association (GMiA) have strongly welcomed the…


Chile remains on USTR Priority Watch list


The Office of the United States Trade Representative (USTR) released its annual Special 301 Report on…

GenericsLegalNorth AmericaPatentsPharmaceuticalSouth America

Asthma pill more user-friendly than inhalers - and no less effective


Rarely prescribed asthma drug in tablet form are easier to use and just as effective as conventional…

AccolateGlaxoSmithKlineMerck & CoPharmaceuticalResearchRespiratory and PulmonarySingulair

US FTC finds 60% rise in pharma pay-for-delay deals; flawed understanding says GPhA


Pharmaceutical companies in the USA struck an unprecedented number of deals in fiscal year 2010 in which…

GenericsLicensingNorth AmericaPharmaceutical

Non-Hodgkins lymphoma drug market set to more than double by 2019


Driven by the launches of premium-priced therapies, the non-Hodgkin’s lymphoma drug market will…

ArzerraGlaxoSmithKlineMarkets & MarketingOncologyPharmaceuticalRituxanrituximabRoche

Teva to buy Japanese generic drugmaker Taiyo?


According to Japan’s leading financial newspaper, The Nikkei, Israeli generics drug giant Teva Pharmaceutical…

Asia-PacificGenericsMergers & AcquisitionsTaiyo PharmaTeva Pharmaceutical Industries

Mylan's 1st-qtr 2011 adjusted diluted EPS up 22%, in line with forecasts


US generics group Mylan (Nasdaq: MYL) reported that total revenues for the quarter ended March 31, 2011…

FinancialGenericsMylan Laboratories

European Commission opens investigation against Cephalon and Teva


The European Commission has opened a formal antitrust investigation to assess whether an agreement between…

CephalonEuropeGenericsLegalTeva Pharmaceutical Industries

Hikma must sell two drugs as condition of Baxter Healthcare acquisition, says US antitrust body


The USA’s Federal Trade Commission will require Jordan-based drugmaker Hikma Pharmaceuticals (LSE:…

Baxter HealthcareGenericsHikma PharmaceuticalsLegalMergers & Acquisitions

GlaxoSmithKline 1st-qtr 2011 sales and earnings down but firm back in the black; Lovaza subpoena


After revealing a more than $1 billion loss for the fourth quarter of 2010 as a result of legal charges…


Generic drug sales in Brazil leapt 53% in 2010; double-digit growth forecast the next two years


In Brazil, sales last year of generic drugs - which are nearly identical reproductions of off-patent…

GenericsMarkets & MarketingPatentsSouth America

Watson 1st-qtr 2011 net revenue Increases 2.3% to $877 million


USA-based generics and specialty drugmaker Watson Pharmaceuticals (NYSE: WPI) reported net revenue of…

FinancialGenericsPharmaceuticalWatson Pharmaceuticals

Hospira’s first-quarter 2011 results beat forecasts, helped by generic Taxotere


Specialty drugmaker Hospira (NYSE: HSP) yesterday reported results for the first quarter ended March…


Kaketsuken initiates second trial of flu vaccine using Vivalis EB66 cell line


Japan’s Chemo-Sero-Therapeutic Research Institute (Kaketsuken) has initiated the first human injection…

GlaxoSmithKlineKaketsukenPharmaceuticalResearchRespiratory and PulmonaryVaccinesVivalis

1620 to 1643 of 1643 results

Back to top